Etomidate

Etomidate · ETOMIDATE 40 mg/20mL · Injection, Solution · Intravenous · Eugia US LLC

NDC 55150-0222-20 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$63.50

Reported to Texas DSHS · 2026 annual filing · Eugia Us Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$740

135 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Eugia Pharma Specialities LimitedOAIIndia
analysis · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA206126
TE code: AP
Approval date: Feb 24, 2017
Patents / exclusivity: None on file

Shortage history

In shortage now — Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)Oct 5, 2022
Other
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/mL (NDC 72485-508-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10)Oct 5, 2022
Demand increase for the drug
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2mg/mL (NDC 65219-447-20)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20)Oct 5, 2022
Demand increase for the drug
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Etomidate (Injection, Solution)

Labeler	Strength	First seen	Last seen
Eugia US LLC	ETOMIDATE 20 mg/10mL	Jul 15, 2026	Sep 2, 2026
Eugia US LLC	ETOMIDATE 40 mg/20mL	Jul 15, 2026	Sep 2, 2026
Henry Schein, Inc.	ETOMIDATE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirst	ETOMIDATE 40 mg/20mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	ETOMIDATE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
Armas Pharmaceuticals Inc.	ETOMIDATE 2 mg/mL	Jul 15, 2026	Aug 31, 2026
Caplin Steriles Limited	ETOMIDATE 2 mg/mL	Jul 15, 2026	Aug 31, 2026
Fresenius Kabi USA, LLC	ETOMIDATE 2 mg/mL	Jul 15, 2026	Aug 31, 2026
Mylan Institutional LLC	ETOMIDATE 2 mg/mL	Jul 15, 2026	Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Etomidate — NDC 55150-0222-20," retrieved September 3, 2026, https://drugdashboards.com/drug/55150022220.

Free to cite with attribution — see how the data is put together.